FDA & MoCRA for False Eyelashes: A Practical Compliance Guide

Selling false eyelashes in the United States means more than a good product and a pretty box. Since the Modernization of Cosmetics Regulation Act (MoCRA) took effect, the compliance surface for lash brands has grown, especially for brands that also sell glue, removers or anything applied near the eye. This guide explains, in practical terms, how the FDA treats false eyelashes, what MoCRA changed, what a brand founder actually needs to do before the first US shipment lands, and how compliance intersects with retailer and marketplace requirements.

This is educational guidance, not legal advice. Requirements differ by product type, claim set, and business size; always confirm current obligations for your specific SKUs with a regulatory professional and your supplier's documentation.

How the FDA Classifies False Eyelashes

The short version: the lashes themselves are generally treated as cosmetic articles, while adhesives and removers applied to skin are cosmetics (and can be drugs if they claim drug benefits). The exact obligations, however, depend on the product type, how it is used, and what claims you make, and not every lash-adjacent product carries the same duties. Work through your SKUs one by one:

• False eyelashes (strip, cluster, individual, magnetic without adhesive): regulated as cosmetics. Must be safe, properly labeled, and manufactured under sanitary conditions.
• Lash glue / adhesive: a cosmetic applied to skin, subject to ingredient, labeling and facility rules. Glue with "grow," "heal," "treat" claims may be classified as a drug (much higher burden: premarket approval or OTC monograph pathways).
• Removers: same logic as glue, cosmetic unless drug claims are made.
• Magnetic lashes with iron particles: still cosmetic articles, but magnetic components add a safety-consideration layer worth documenting (strength, particle containment).

Ingredient screening matters most for glue. The EU's REACH restrictions (see our REACH compliance guide) have already pushed most reputable factories away from problematic adhesive ingredients; US sellers should confirm the same ingredient discipline even when not legally required by REACH, because it is the practical baseline serious factories already meet.

What MoCRA Changed for Lash Brands

MoCRA modernized FDA's cosmetics authority. The key obligations relevant to lash brands:

1. Facility registration & product listing: Most cosmetic manufacturing facilities must register with the FDA, and responsible entities must list products (with ingredient statements and other data). Important: FDA provides limited exemptions from facility registration and product listing for certain small businesses, but these exemptions do not apply to every product category or situation, so do not assume your factory or your SKUs qualify without checking current FDA guidance for your specific case. If your factory already registers and lists, confirm your SKUs are included. Do not assume every private label SKU appears under your brand.
2. Responsible person: Someone must be designated for each product (usually the US brand owner or importer), with name and contact on the label, reachable by the FDA for adverse events and compliance matters.
3. Adverse event reporting: Serious adverse events must be reported to the FDA within 15 business days; records of all adverse events (serious and non-serious) must be kept for six years. Build an intake channel (a support email or form) before launch, not after your first complaint.
4. Good manufacturing practices: MoCRA establishes a legal framework for cosmetic GMP, but the specific standards and their implementation are still evolving through FDA rulemaking. In practice, ask your supplier for the quality management system they actually run (documented procedures, batch records, material controls) rather than asking only whether they "follow GMP." Multi-batch testing and documented QC (see how JINYANHUA runs multi-batch safety testing) are the operational expression of that discipline.
5. Labeling: Contact information for the responsible person, fragrance allergen disclosure where applicable, and net quantity / identity statements per longstanding cosmetic labeling practice.
6. Records & safety substantiation: Products must be substantiated as safe under labeled or customary use conditions; formulation and safety records should be retrievable.

Labeling Checklist for US Lash Products

• Product identity ("false eyelashes," "lash clusters," etc.)
• Net quantity statement
• Name and place of business of manufacturer, packer or distributor
• Responsible person name and contact (MoCRA)
• Country of origin (customs requirement)
• Material content where relevant; warnings for glue (avoid eye contact, keep out of reach of children, discontinue if irritation occurs)
• Batch/lot code traceability, which you need for targeted recalls and adverse event response

Print responsible-person details in the first packaging round, not as a sticker afterthought; retro-fitting labels is expensive and visible to customers.

Practical Steps Before Your First US Shipment

1. Ask your supplier for compliance documentation: ingredient lists (for glue), material declarations, GMP statements, test reports (heavy metals, microbial where applicable, irritation/sensitization for adhesives). Reputable factories keep these ready; hesitation is a risk signal.
2. Confirm facility registration & product listing status for your SKUs, or plan to complete them under your responsible-person entity. Keep confirmation emails.
3. Audit your marketing claims: no drug claims on glue or lashes ("stimulates growth," "treats sparse lashes," "heals"). Claim review should cover your website, marketplace listings, ads and packaging copy. One wild claim on a packaging insert can reframe the product legally.
4. Designate your responsible person and put the required contact info on labels before printing.
5. Keep batch records linking every shipment to production lots, and retain safety substantiation documents.
6. Build an adverse-event intake process: a support channel, an internal escalation path, and a template for FDA serious-adverse-event reporting timelines.

US sellers also need the operational side covered: import duties, customs classification, and shelf-ready labeling are covered in the shipping and logistics guide, and supplier selection with compliance in mind is covered in how to choose a private label supplier.

Beyond the Factory: Retailer & Marketplace Requirements

FDA/MoCRA compliance is the floor; retail and marketplace gates can be stricter in practice:

• Major retailers (beauty chains, department stores) typically vendor-qualify with their own supplier audits, insurance requirements and sometimes exclusivity terms; factory GMP documentation becomes your entry ticket.
• Amazon and large marketplaces require category compliance documentation and can request test reports on complaint spikes; listing suspension risk is real for undocumented sellers.
• Insurance: product liability insurance is effectively mandatory for wholesale channels; premiums reflect your documentation quality.

Brands that treat compliance as a retailer-entrance asset instead of a legal checkbox close wholesale accounts faster. Pair this with the commercial foundation in the retailer sourcing guide.

What Changes If You Sell in the EU or UK Too

Quick orientation (details in the REACH guide): EU cosmetics regulation (EC 1223/2009) adds a Responsible Person established in the EU, CPNP notification, and REACH restrictions that can apply to specific adhesive ingredients depending on substance, concentration, and product use, so review your glue's full formulation, classification, labeling, and target market with a regulatory specialist rather than assuming a single universal limit covers all lash adhesives. UK post-Brexit follows its own UK Cosmetics Regulation with UK RP and SCPN notification. A dual-market brand should spec glue to the strictest applicable requirements once, not maintain two formulations unless volume justifies it.

State-Level and Channel-Level Extra Rules

Federal MoCRA compliance is the baseline; two additional layers commonly affect lash brands selling in the US:

• California Proposition 65: if your products (especially adhesives) contain listed chemicals above safe-harbor levels and exposure meets the applicable threshold, California requires warnings. Whether a warning is needed depends on the specific chemicals in your formulation, the exposure scenario, and current Prop 65 rules. Do not assume a blanket warning is always the right or only answer. Start by asking your factory's compliance desk whether your glue formulation triggers this, get the answer in writing, and decide on warning or reformulation with that data in front of you.
• State cosmetics registration programs: a few states have their own cosmetics-related registration or notification requirements that sit on top of federal rules. These change over time; a quick annual check with your compliance advisor is cheaper than a surprise takedown notice.
• Marketplace and retailer overlays: Amazon, Walmart, Target and beauty chains each maintain category compliance checklists that can require test reports (heavy metals, microbes, irritation for adhesives) beyond the federal minimum. Build the document pack once (GMP statement, ingredient lists, test reports, liability insurance) and reuse it across channels; this is the fastest path from DTC to wholesale-ready.
• Children's product adjacency: if you market "starter kits" or styles aimed at minors, additional scrutiny frameworks can apply, so position teen-targeted lashes carefully and avoid any claims that blur cosmetic and drug territory.

Frequently Asked Questions

Are false eyelashes FDA approved?

Cosmetics (including lashes) do not receive pre-market FDA approval. They must be safe and properly labeled, and facilities/products must meet MoCRA registration and listing requirements.

Does lash glue need special registration?

Lash glue is a cosmetic; it must meet the same MoCRA obligations. If you make drug-like claims, the product may be regulated as a drug. Avoid such claims everywhere, including influencer briefs.

Who is the "responsible person" under MoCRA?

The entity responsible for ensuring a cosmetic product meets requirements, typically the US brand owner or importer for private label brands selling into the US. Their contact must appear on the label.

What is the penalty for non-compliance?

The FDA can issue warnings, mandate recalls, or pursue legal action. Beyond penalties, non-compliant products create marketplace and retailer delisting risk; compliance is insurance for your brand.

Do I need a lab test for every batch?

Routine third-party testing of every batch is not universally mandated for lashes; what is required is safety substantiation and a documented quality system. Many brands test the first production batch per SKU, annually thereafter, plus whenever formulations change, a defensible middle path. Confirm current expectations for your specific products with your regulatory advisor.

How do I handle a customer eye irritation complaint?

Document it (photos, product lot, usage description), assess seriousness (medical attention = serious adverse event), keep records, and report serious events within the required window. Root-cause it with your factory using the batch code; this is why lot traceability matters.

Compliance starts with the right factory. JINYANHUA maintains multi-batch safety testing and documentation support for private label brands entering regulated markets. Review our compliance approach or request documentation with your quote.